Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Mirion Technologies, Inc. (GSAH)
|
|
| Segments |
Business | Product |
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-23 | Jun-30-22 | Mar-31-22 | Oct-19-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K/A |
| Revenues |
| Medical | 66.4 | 66.8 | 60.1 | 60.3 | | 52.1 | 51.5 | |
| United States | | | | 100.0 | | | | |
| France | | | | 35.1 | | | | |
| Industrial | 115.7 | 109.0 | 103.1 | 107.7 | | 127.9 | 77.8 | |
| Point in time | 118.3 | 117.2 | 117.0 | 123.6 | | 132.6 | 121.4 | |
| Over time | 63.8 | 58.6 | 46.2 | 44.4 | | 47.4 | 44.8 | |
| Asia Pacific | 7.4 | 1.3 | 7.7 | 1.7 | | 1.8 | 9.2 | |
| Europe | 58.8 | 63.0 | 57.7 | 58.3 | | 70.4 | 66.0 | |
| North America | 115.9 | 111.5 | 97.8 | 108.0 | | 107.8 | 91.0 | |
| |
| EBITDA |
| Medical | 0.7 | -0.1 | -6.7 | 14.0 | | -0.4 | -2.3 | |
| Industrial | 5.5 | -45.3 | -2.5 | 24.1 | | 29.9 | 17.8 | |
| |
| EBIT |
| Medical | 0.7 | -0.1 | -6.7 | 0.7 | | -0.4 | -2.3 | |
| Industrial | 5.5 | -45.3 | -2.5 | 11.7 | | 29.9 | 17.8 | |
| |
| Mix |
| Medical | 36.5% | 38.0% | 36.8% | 35.9% | | 28.9% | 31.0% | |
| United States | | | | 59.5% | | | | |
| France | | | | 20.9% | | | | |
| Industrial | 63.5% | 62.0% | 63.2% | 64.1% | | 71.1% | 46.8% | |
| Point in time | 65.0% | 66.7% | 71.7% | 73.6% | | 73.7% | 73.0% | |
| Over time | 35.0% | 33.3% | 28.3% | 26.4% | | 26.3% | 27.0% | |
| Asia Pacific | 4.1% | 0.7% | 4.7% | 1.0% | | 1.0% | 5.5% | |
| Europe | 32.3% | 35.8% | 35.4% | 34.7% | | 39.1% | 39.7% | |
| North America | 63.6% | 63.4% | 59.9% | 64.3% | | 59.9% | 54.8% | |
| |
| Growth |
| Medical | 10.5% | 28.2% | 16.7% | | | | | |
| Industrial | 12.2% | -14.8% | 32.5% | | | | | |
| Point in time | 1.1% | -11.6% | -3.6% | | | | | |
| Over time | 38.1% | 23.6% | 3.1% | | | | | |
| Asia Pacific | -3.9% | -27.8% | -16.3% | | | | | |
| Europe | 1.9% | -10.5% | -12.6% | | | | | |
| North America | 18.5% | 3.4% | 7.5% | | | | | |
|